Jacqueline G O'Leary1, Florence Wong2, K Rajender Reddy3, Guadalupe Garcia-Tsao4, Patrick S Kamath5, Scott W Biggins6, Michael B Fallon7, Ram M Subramanian8, B Maliakkal9, Leroy Thacker10, Jasmohan S Bajaj10,11. 1. Division of Hepatology, Baylor Simmons Transplant Institute, Annette C. & Harold C. Simmons Transplant Institute, Baylor University Medical Center, 3410 Worth St, Suite 860, Dallas, TX, 75246, USA. dr_jackieo@yahoo.com. 2. Department of Medicine, University of Toronto, Toronto, ON, Canada. 3. Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA. 4. Department of Medicine, Yale University, New Haven, CT, USA. 5. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA. 6. Department of Medicine, University of Colorado Denver, Denver, CO, USA. 7. Department of Medicine, University of Texas Health Science Center, Houston, TX, USA. 8. Department of Medicine, Emory University, Atlanta, GA, USA. 9. Department of Medicine, University of Rochester, Rochester, NY, USA. 10. Department of Medicine, Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University, Richmond, VA, USA. 11. McGuire VA Medical Center, Richmond, VA, USA.
Abstract
BACKGROUND: Women have lower serum creatinine values than men for similar renal function. AIMS: We aimed to determine the differential effect of baseline, peak, and delta creatinine between genders on outcomes in infected hospitalized cirrhotic patients. METHODS: North American Consortium for the Study of End-Stage Liver Disease is a 15-center consortium of tertiary care hepatology centers prospectively enrolling infected cirrhotic inpatients. Baseline, peak, and delta creatinine during hospitalization were compared between genders, and their impact on overall survival, transplant-free survival, probability of transplantation, and need for renal replacement therapy (RRT) was analyzed. RESULTS: In total, 532 patients with cirrhosis (males = 59% median admission MELD = 20) had significantly lower median baseline (1.07 vs. 1.30 mg/dL, p < 0.0001) and peak creatinine (1.47 vs. 1.59 mg/dL, p = 0.024) in women than men during hospitalization for an infection, but both genders had similar delta creatinine levels (0.30 vs. 0.30 mg/dL, p = 0.957). Thirty-day mortality was similar between genders. RRT was not used more often in women (19 vs. 12%, p = 0.050), and women were 1.8 times more likely than men to receive RRT at the same creatinine (p = 0.028). Both peak and delta creatinine significantly predicted 6-month overall and transplant-free survival (p < 0.0001), but the probability of liver transplantation was affected by the interaction between gender and both peak and delta creatinine. CONCLUSIONS: Infected hospitalized cirrhotic women are significantly more likely than men to receive RRT at similar creatinine levels. Gender-specific differences in baseline, peak, and delta creatinine need further investigation to determine whether women need acute kidney injury treatment at lower creatinine thresholds than men.
BACKGROUND:Women have lower serum creatinine values than men for similar renal function. AIMS: We aimed to determine the differential effect of baseline, peak, and delta creatinine between genders on outcomes in infected hospitalized cirrhotic patients. METHODS: North American Consortium for the Study of End-Stage Liver Disease is a 15-center consortium of tertiary care hepatology centers prospectively enrolling infected cirrhotic inpatients. Baseline, peak, and delta creatinine during hospitalization were compared between genders, and their impact on overall survival, transplant-free survival, probability of transplantation, and need for renal replacement therapy (RRT) was analyzed. RESULTS: In total, 532 patients with cirrhosis (males = 59% median admission MELD = 20) had significantly lower median baseline (1.07 vs. 1.30 mg/dL, p < 0.0001) and peak creatinine (1.47 vs. 1.59 mg/dL, p = 0.024) in women than men during hospitalization for an infection, but both genders had similar delta creatinine levels (0.30 vs. 0.30 mg/dL, p = 0.957). Thirty-day mortality was similar between genders. RRT was not used more often in women (19 vs. 12%, p = 0.050), and women were 1.8 times more likely than men to receive RRT at the same creatinine (p = 0.028). Both peak and delta creatinine significantly predicted 6-month overall and transplant-free survival (p < 0.0001), but the probability of liver transplantation was affected by the interaction between gender and both peak and delta creatinine. CONCLUSIONS: Infected hospitalized cirrhotic women are significantly more likely than men to receive RRT at similar creatinine levels. Gender-specific differences in baseline, peak, and delta creatinine need further investigation to determine whether women need acute kidney injury treatment at lower creatinine thresholds than men.
Entities:
Keywords:
Acute kidney injury; Female; Gender; Liver transplant; Renal function
Authors: Florence Wong; Jacqueline G O'Leary; K Rajender Reddy; Heather Patton; Patrick S Kamath; Michael B Fallon; Guadalupe Garcia-Tsao; Ram M Subramanian; Raza Malik; Benedict Maliakkal; Leroy R Thacker; Jasmohan S Bajaj Journal: Gastroenterology Date: 2013-08-30 Impact factor: 22.682
Authors: Paolo Angeli; Pere Ginès; Florence Wong; Mauro Bernardi; Thomas D Boyer; Alexander Gerbes; Richard Moreau; Rajiv Jalan; Shiv K Sarin; Salvatore Piano; Kevin Moore; Samuel S Lee; Francois Durand; Francesco Salerno; Paolo Caraceni; W Ray Kim; Vicente Arroyo; Guadalupe Garcia-Tsao Journal: J Hepatol Date: 2015-01-28 Impact factor: 25.083
Authors: E Cholongitas; L Marelli; A Kerry; D W Goodier; D Nair; M Thomas; D Patch; A K Burroughs Journal: Am J Transplant Date: 2007-01-11 Impact factor: 8.086
Authors: Robert P Myers; Abdel Aziz M Shaheen; Alexander I Aspinall; Robert R Quinn; Kelly W Burak Journal: J Hepatol Date: 2010-09-19 Impact factor: 25.083
Authors: P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim Journal: Hepatology Date: 2001-02 Impact factor: 17.425
Authors: Cynthia A Moylan; Carla W Brady; Jeffrey L Johnson; Alastair D Smith; Janet E Tuttle-Newhall; Andrew J Muir Journal: JAMA Date: 2008-11-26 Impact factor: 56.272
Authors: Rajiv Jalan; Faouzi Saliba; Marco Pavesi; Alex Amoros; Richard Moreau; Pere Ginès; Eric Levesque; Francois Durand; Paolo Angeli; Paolo Caraceni; Corinna Hopf; Carlo Alessandria; Ezequiel Rodriguez; Pablo Solis-Muñoz; Wim Laleman; Jonel Trebicka; Stefan Zeuzem; Thierry Gustot; Rajeshwar Mookerjee; Laure Elkrief; German Soriano; Joan Cordoba; Filippo Morando; Alexander Gerbes; Banwari Agarwal; Didier Samuel; Mauro Bernardi; Vicente Arroyo Journal: J Hepatol Date: 2014-06-17 Impact factor: 25.083
Authors: Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin Journal: Crit Care Date: 2007 Impact factor: 9.097
Authors: Jessica B Rubin; Yanin T Srisengfa; Somaya Albhaisi; Chathur Acharya; Gayatri Nangia; Tahira Shaikh; Leroy R Thacker; K Rajender Reddy; Puneeta Tandon; Jasmohan S Bajaj; Jennifer C Lai Journal: Clin Gastroenterol Hepatol Date: 2019-10-05 Impact factor: 11.382
Authors: Gabrielle E Hatton; Reginald E Du; Claudia Pedroza; Shuyan Wei; John A Harvin; Kevin W Finkel; Charles E Wade; Lillian S Kao Journal: J Am Coll Surg Date: 2019-09-20 Impact factor: 6.113
Authors: Georg P Györi; David Pereyra; Benedikt Rumpf; Hubert Hackl; Christoph Köditz; Gregor Ortmayr; Thomas Reiberger; Michael Trauner; Gabriela A Berlakovich; Patrick Starlinger Journal: Hepatology Date: 2020-04-23 Impact factor: 17.425
Authors: Patrick Starlinger; Joseph C Ahn; Aidan Mullan; Georg P Gyoeri; David Pereyra; Roberto Alva-Ruiz; Hubert Hackl; Thomas Reiberger; Michael Trauner; Jonas Santol; Benedikt Simbrunner; Mattias Mandorfer; Gabriela Berlakovich; Patrick S Kamath; Julie Heimbach Journal: Hepatology Date: 2021-08-29 Impact factor: 17.425
Authors: Marie Griemsmann; Tammo L Tergast; Nicolas Simon; Abdul-Rahman Kabbani; Michael P Manns; Heiner Wedemeyer; Markus Cornberg; Benjamin Maasoumy Journal: Sci Rep Date: 2022-02-28 Impact factor: 4.996